For critically ill patients on antibiotics for suspected sepsis, monitoring one biomarker safely shortened the course of these medications in the ADAPT-Sepsis randomized trial. Daily assessment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results